Skip to content
Subscriber Only

They Can’t Get Their Meds. So They’re Moving to Scotland

Families in England are preparing to leave the country in a desperate bid to obtain a cystic fibrosis drug not available at home.

Parents protest in England against an NHS decision to exclude coverage of Orkambi, an expensive drug to treat cystic fibrosis.  

Parents protest in England against an NHS decision to exclude coverage of Orkambi, an expensive drug to treat cystic fibrosis.  

Photographer: Dominic Lipinski/PA via Getty Images
Updated on

Soon after Emma Corr, a teacher in northeast England, gave birth to her second daughter in 2014, she was devastated to learn that her baby had cystic fibrosis, a life-shortening genetic disease that causes severe lung damage. Then she heard about a promising new drug nearing the market that might transform her child’s life.

“It was a glimmer of hope at a very dark time,” says Corr, whose daughter, Harriet, is one of 10,000 people in the U.K. afflicted with the illness.